SUBSCRIBE
SUBSCRIBE
News   Business

Ark Therapeutics Signs Chinese Marketing Deal For Kerraboot Ulcer Product

February 15, 2006 | 
1 min read
Ark Therapeutics Group PLC said it has signed an exclusive licensing deal for its Kerraboot wound care device for the management of leg and foot ulcers with Chinese healthcare company Sino Tau International Company Lld in China.
Alliances Europe
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Amgen Trims Horizon Subsidiary, f5 Shuts Down
March 11, 2026
 · 
33 min read
 · 
BioSpace Editorial Staff
Podcast
Prasad Out at FDA, Lawmaker Takes Action on Rare Disease Rejections and a Spate of Obesity Data
March 11, 2026
 · 
1 min read
 · 
Heather McKenzie
BioNTech CEO Ugur Sahin and Chief MEdical Officer Özlem Türeci.
C-suite
BioNTech Founders To Leave Famed mRNA Biotech for New Venture
March 10, 2026
 · 
2 min read
 · 
Annalee Armstrong
change business management, businessman turn gear cog to manage change direction arrows, professional or expertise to manage company transformation or implement new process concept vector illustration
Manufacturing
Cell and Gene Therapy Manufacturing Market To Skyrocket to $146B by 2032
March 10, 2026
 · 
3 min read
 · 
Nick Paul Taylor